Genetic testing for inherited ocular conditions in a developing country

Simple item page
dc.coverageDOI: 10.1080/13816810.2020.1734944
dc.creatorZanolli, Mario
dc.creatorOporto, Joaquín I.
dc.creatorVerdaguer, Juan I.
dc.creatorLópez, Juan Pablo
dc.creatorZacharías, Sergio
dc.creatorRomero, Pablo
dc.creatorOssandón, Diego
dc.creatorDenk, Oliver
dc.creatorAcuña, Olga
dc.creatorLópez, José Manuel
dc.creatorStevenson, Ricardo
dc.creatorÁlamos, Bernardita
dc.creatorIturriaga, Hernán
dc.date2020
dc.date.accessioned05-01-2026 18:08
dc.date.available05-01-2026 18:08
dc.description<p>Background: Inherited ocular conditions are a frequent cause of blindness. Gene therapy has encouraged the development of genetic testing, currently able to detect up to 80% of mutations in contrast to the 5% sensitivity achieved a few decades ago. Materials and methods: One hundred sixty-three patients with suspected genetic ocular disorders who were referred to a single clinician between August 2014 and August 2019 underwent a thorough ophthalmologic examination. Those diagnosed with congenital cataract, retinoblastoma, anterior segment dysgenesis, autoimmune retinal disease, posterior microphthalmia, or cobalamin C deficiency were excluded, along with patients who opted against genetic testing. Included probands were classified into a diagnostic clinical category and offered genetic testing. Blood samples were sent to foreign accredited diagnostic laboratories, followed by clinical interpretation of the results. Results: Of the 163 patients referred, 104 were enrolled in the study. Median age at disease onset was 2 years (range, 0 to 43 years). A molecular diagnosis was established at a median age of 10 years (range, 0.4 to 50 years). Disease-causing genotypes were identified in 82 of the probands, indicating a mutation detection rate of 78.8%. Mutations were identified in 38 genes, ABCA4 being the most commonly affected (23% of mutations), followed by CRB1 (13% of mutations). Whole-exome sequencing was performed in 6 patients, resulting in a definite diagnosis in 3 (50%). Conclusions: Molecular testing for inherited ocular conditions is feasible in developing countries by sending samples to certified foreign laboratories, with a mutation detection rate comparable to published values in developed countries. Further studies to identify more disease-causing genes may improve the overall sensitivity.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/c83b1ec3-621a-4204-92fe-407f3b384beb
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.41 (2020) date: 2020-01-02 nr.1 p.36-40
dc.subjectABCA4
dc.subjectgenetic testing
dc.subjectInherited ocular conditions
dc.subjectLeber’s congenital amaurosis
dc.subjectsensitivity
dc.titleGenetic testing for inherited ocular conditions in a developing countryeng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
Pure-CRIS